An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile.

J Exp Clin Cancer Res · 2022 · PMC8903172 · PMID 35260172

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The differential response of CTCDOs and XDOs to YM155 was further confirmed by a dose-response cytotoxicity assay showing a highly significant difference starting from a dose of 50 nM (Fig. 5 C).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.